CASP3 and acute lung injury: Based on the analysis of network pharmacology and GO and KEGG enrichment, we obtained a research hypothesis: L-Clausenamide treats LPS-induced acute lung injury by regulating oxidative stress to improve mitochondrial damage and reducing the CASP3-induced apoptosis.